Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Hunter Holdings is a private investment and holding company that primarily operates through its subsidiaries and direct capital investments in various sectors, including life sciences, healthcare, and energy. The firm is most notably recognized as the parent company of Global Hunter Securities, an investment bank that provided specialized research, trading, and investment banking services to the healthcare and biotechnology industries. Through its leadership, the company has maintained significant ties to the biotech sector, with key principals serving on the boards of major pharmaceutical companies such as Novavax. Global Hunter Holdings focuses on identifying high-growth opportunities and providing the capital and strategic oversight necessary for commercial expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Hunter Holdings.